Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Mazzarella

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Nature Communications|January 27, 2024
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansionRani Pallavi, Elena Gatti, Tiphanie Durfort, et al.
Nature Cell Biology|May 18, 2010
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulatorsDavid Landeira, Stephan Sauer, Raymond Poot, et al.
Mucosal Immunology|April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesisGeorgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Mucosal Immunology|December 11, 2025
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Giovanni Marconi, Pau Montesinos, et al.
Clinical Lung Cancer|March 1, 2021
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung CancerVanesa Gregorc, Luca Mazzarella, Chiara Lazzari, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2025
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL ConsortiumGennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Nature Communications|January 27, 2024
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansionRani Pallavi, Elena Gatti, Tiphanie Durfort, et al.
Nature Cell Biology|May 18, 2010
Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulatorsDavid Landeira, Stephan Sauer, Raymond Poot, et al.
Mucosal Immunology|April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesisGeorgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Mucosal Immunology|December 11, 2025
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Giovanni Marconi, Pau Montesinos, et al.
Clinical Lung Cancer|March 1, 2021
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung CancerVanesa Gregorc, Luca Mazzarella, Chiara Lazzari, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2025
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL ConsortiumGennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
Science Signaling|December 19, 2023
Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronavirusesLuca Mazzarella, Fabio Santoro, Roberto Ravasio, et al.
Nature Cancer|June 30, 2025
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trialEdith Borcoman, Bastien Cabarrou, Miguel Francisco, et al.
Pageof 9